Yumanity Therapeutics and the New York Stem Cell Foundation Research Institute Announce Discovery Collaboration

“We are thrilled to be partnering with the NYSCF Research Institute ... Parkinson’s disease and amyotrophic lateral sclerosis (ALS). Leveraging its three integrated platforms, Yumanity’s innovative new approach to drug discovery and development ...